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in English or Spanish per patient preferences. Interview participation was similar by ethnicity. 7 Patients with their first Brain Attack Surveillance in Corpus Christi stroke (ischemic or hemorrhagic) were included. This project was approved by the University of Michigan and both Corpus Christi Health Systems' Institutional Review Boards. Informed consent was obtained from all subjects.
Variables
Patients reported prestroke hypertension (physician diagnosis of high blood pressure ever) and its treatment (use of antihypertensive medication) at the time of the index stroke.
All covariates, including race-ethnicity (non-Hispanic white [NHW], MA), were self-reported except insurance status (medical record) and selected using the Andersen Behavioral Model framework. 10 EP was speaking English only or bilingual (more accultured). Limited EP was speaking Spanish only (less accultured). Months from last physician visit to stroke (0-6, 6-12, 12-24, >24, and never) were recorded.
Of 1111 stroke cases identified, we excluded 328 with previous stroke/transient ischemic attack, 89 with other race-ethnicity, and 26 with no information on the outcome, leaving 763 cases in the study.
Statistical Analysis
We evaluated correlates of ethnicity (NHWs=referent) and hypertension treatment status using χ 2 test or ANOVA. We used multivariable logistic regression models to examine the association between ethnicity and hypertension treatment before and after adjusting for covariates: (1) overall and within education strata (<high school, high school, ≥high school) and (2) after stratifying MAs by EP. We also compared hypertension treatment by ethnicity among those with diabetes mellitus.
11
Income was significantly correlated with education (coefficient 0.54; P<0.001) so we included education alone and did sensitivity analyses adjusting for income. 4 We examined interaction terms (ethnicity-by-education and ethnicity-by-EP) in the adjusted models. MAs had similar likelihood of hypertension treatment before stroke overall, within education strata, and after dichotomizing MAs by EP (Table; online-only Data Supplement). Hypertension treatment was lower in uninsured patients (adjusted odds ratio, 0.13; 95% confidence interval, 0.03-0.60) or those with no physician visit ≤6 months (adjusted odds ratio, 0.09; 95% confidence interval, 0.03-0.24). There were no ethnic differences in treatment in analyses that used medical record diagnosis of hypertension or that included income (online-only Data Supplement).
Results

Hypertension treatment was similar in MAs and
Discussion
We found no evidence that SES or acculturation modifies the association between ethnicity and hypertension treatment before stroke. Several factors potentially explain our findings. Most MAs in our study were born in the United States and insured (93%). Health insurance accounts for the largest proportion of the Hispanic-white disparity in access to physician care. 12 Health insurance and access to care differences may be greater in communities with more MA immigrants. Alternatively, we may have been unable to detect small ethnic differences in prestroke treatment because of sample size (n=520). On the basis of a post hoc analysis, we had 80% power (α=0.05) to detect an absolute hypertension treatment rate for MAs that was either 10% lower or 8% higher than that of NHWs (84%). Finally, ethnic differences in treatment of vascular risk factors at the population-level may vary by geographic region and may even be absent in some communities or subpopulations. 13 Our study has limitations. We lacked information on control or duration of hypertension. Hispanics have worse hypertension control than whites, and this gap persisted between 1999 and 2006.
14 Despite similar treatment rates, MAs may have worse prestroke hypertension control than NHWs. Moreover, our study does not preclude that ethnic differences in hypertension prevalence, treatment, or control contribute to MAs' higher stroke incidence. 3 Neither SES nor acculturation amplified ethnic differences in hypertension treatment. There was a tendency for MAs and NHWs with higher SES to have lower hypertension treatment rates before stroke, which is counterintuitive to expected trends.
